Taking Stock
Merrimack's Mulroy on Success of Pancreatic Drug Onivyde(Audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:00
- Mas informaciones
Informações:
Sinopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.
